NeuroPace, Inc.

NASDAQ:NPCE

Medical - Devices

Healthcare
$8.14 +0.30%

+$0.05 today

Market cap
$280.44M
Beta
1.88
P/E (TTM)
-23.8
EPS (TTM)
-$0.64
52W Low $7.56High $19.60

Volume 0.35M

Average 0.18M

Income Statement

Follow revenue through to earnings.

Revenue

$99.99M

FY 2025 · Annual

+25.1% YoY

Operating Income

-$16.34M

FY 2025 · Annual

Net Income

-$21.46M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue45.18M45.52M65.42M79.91M99.99M
Cost of Revenue11.75M13.03M17.3M20.82M22.77M
Gross Profit33.44M32.49M48.12M59.09M77.22M
Gross Margin74.0%71.4%73.6%73.9%77.2%
Research & Development18.21M21.95M20.78M23.65M27.89M
Selling, General & Admin38.96M51.34M54.52M57.1M65.67M
Operating Expenses57.17M73.29M75.3M80.76M93.56M
Depreciation & Amortization296K2.99M1.61M1.77M1.95M
EBITDA(28.37M)(36.57M)(22.83M)(16.57M)(12.06M)
EBITDA Margin-62.8%-80.3%-34.9%-20.7%-12.1%
Operating Income(23.74M)(40.79M)(27.17M)(21.67M)(16.34M)
Operating Margin-52.5%-89.6%-41.5%-27.1%-16.3%
Interest Income448K1.58M3.05M3.02M2.82M
Interest Expense7.41M7.53M8.52M8.8M7.46M
Other Income / Expenses(12.34M)(6.29M)(5.78M)(5.47M)(5.13M)
Income Before Tax(36.08M)(47.08M)(32.96M)(27.14M)(21.47M)
Pre-Tax Margin-79.9%-103.4%-50.4%-34.0%-21.5%
Income Tax Expense00000
Net Income(36.08M)(47.08M)(32.96M)(27.14M)(21.47M)
Net Margin-79.9%-103.4%-50.4%-34.0%-21.5%
EPS (Basic)(2.17)(1.91)(1.27)(0.93)(0.66)
EPS (Diluted)(2.17)(1.91)(1.27)(0.93)(0.66)
Weighted Avg Shares16.61M24.59M25.85M29.13M32.72M
Weighted Avg Shares (Diluted)16.61M24.59M25.85M29.13M32.72M

NPCE Earnings Waterfall · TTM

NASDAQ:NPCE · Revenue to Net Income

Key Ratios

EPS$-0.65
Gross Margin78.4%
Net Margin-22.5%
P/E Ratio-24.5
P/S Ratio16.8

Analysis

$99.5M of revenue converted into -$21.6M of net income for the selected period. Gross margin is 78.4% and net margin is -22.5%, showing how much revenue survives after costs and taxes. EPS is $-0.65, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipSep 25, 2026
4Statement of changes in beneficial ownershipSep 21, 2026
4Statement of changes in beneficial ownershipSep 4, 2026

How much revenue does NPCE generate?

NeuroPace, Inc. (NPCE) reported $99.99M of revenue in fiscal 2025.

Is NPCE profitable?

NeuroPace, Inc. (NPCE) reported -$21.46M of net income, with a net margin of -21.5%.